Howard M. Shulman
#163,497
Most Influential Person Now
Howard M. Shulman's AcademicInfluence.com Rankings
Howard M. Shulmanphilosophy Degrees
Philosophy
#9518
World Rank
#13093
Historical Rank
Logic
#6492
World Rank
#8014
Historical Rank
Download Badge
Philosophy
Why Is Howard M. Shulman Influential?
(Suggest an Edit or Addition)Howard M. Shulman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. (2005) (3030)
- Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. (1980) (2406)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (2015) (2244)
- National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. (2005) (1947)
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients (1993) (1125)
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. (1981) (883)
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors (1984) (779)
- Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). (2002) (629)
- Marrow transplantation for acute nonlymphoblastic leukemia in first remission. (1979) (628)
- Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. (1997) (618)
- Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. (2006) (440)
- Epstein-Barr virus lymphoproliferation after bone marrow transplantation. (1988) (415)
- Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. (1981) (343)
- Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome. (1996) (332)
- Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. (2006) (299)
- Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. (1983) (295)
- Intestinal and hepatic complications of human bone marrow transplantation. Part I. (1986) (289)
- Chronic cutaneous graft-versus-host disease in man. (1978) (286)
- Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. (2006) (282)
- An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. (1980) (275)
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. (2002) (269)
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report (2006) (261)
- Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms (1994) (253)
- High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. (2007) (247)
- Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. (1989) (245)
- Gastrointestinal graft‐versus‐host disease in man: A clinicopathologic study of the rectal biopsy (1979) (244)
- Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. (1993) (238)
- Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy. (2002) (237)
- The skin biopsy in the diagnosis of acute graft-versus-host disease in man. (1977) (233)
- Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation. (1992) (226)
- Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. (2010) (222)
- Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. (1993) (204)
- The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients (1998) (196)
- Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. (2000) (195)
- NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. (2015) (189)
- Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? (2008) (186)
- Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. (1987) (180)
- A coded histologic study of hepatic graft‐versus‐host disease after human bone marrow transplantation (1988) (159)
- Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. (2004) (157)
- THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION (1985) (156)
- The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients (1980) (156)
- Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. (1995) (155)
- Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. (1986) (155)
- Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. (2006) (155)
- Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. (1991) (150)
- Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS. (2012) (142)
- Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. (2007) (142)
- Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. (1984) (136)
- Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody. (1985) (133)
- Negative Regulators of Hemopoiesis and Stroma Function in Patients with Myelodysplastic Syndrome (2000) (131)
- Chronic graft‐versus‐host disease of the liver: Presentation as an acute hepatitis (2000) (125)
- Late complications after marrow transplantation. (1984) (125)
- Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. (1990) (124)
- Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. (1981) (121)
- Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. (1978) (117)
- Liver disease after human marrow transplantation. (1987) (109)
- Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. (1996) (106)
- The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. (1980) (98)
- Ocular manifestations of graft-v-host disease. (1983) (98)
- Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains. (1997) (97)
- Esophageal abnormalities in chronic graft-versus-host disease in humans (1981) (97)
- Diffuse intestinal ulceration after marrow transplantation: a clinicopathologic study of 13 patients. (1986) (97)
- Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. (1991) (97)
- Allogeneic marrow transplantation in the treatment of preleukemia. (1984) (95)
- Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation (2014) (87)
- Treatment of preleukemic syndromes with marrow transplantation (1987) (87)
- DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. (1995) (86)
- DISORDERED SALIVARY IMMUNOGLOBULIN SECRETION AND SODIUM TRANSPORT IN HUMAN CHRONIC GRAFT‐VERSUS-HOST DISEASE (1983) (85)
- Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. (1999) (84)
- Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. (1994) (74)
- A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. (1990) (73)
- A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. (2000) (73)
- Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis. (2006) (72)
- Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies. (1986) (71)
- Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. (1987) (69)
- Intestinal and hepatic complications of human bone marrow transplantation. Part II. (1986) (68)
- A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation (2015) (67)
- Young rete ridge keratinocytes are preferred targets in cutaneous graft-versus-host disease. (1985) (66)
- Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. (1990) (65)
- Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation. (1998) (65)
- Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission. (1991) (65)
- Bone marrow transplantation for acute myelosclerosis (1981) (62)
- The fine structure of human rectal epithelium in acute graft‐versus‐host disease (1982) (62)
- Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. (1993) (61)
- Abrogation of resistance to and enhancement of DLA-nonidentical unrelated marrow grafts in lethally irradiated dogs by thoracic duct lymphocytes. (1979) (59)
- Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance. (1980) (57)
- Induction of hepatic veno-occlusive disease in dogs. (1987) (54)
- Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. (1990) (54)
- Gastrointestinal radiographic features of human graft-vs.-host disease. (1981) (54)
- Cutaneous Chronic Graft-Versus-Host Disease Does Not Have the Abnormal Endothelial Phenotype or Vascular Rarefaction Characteristic of Systemic Sclerosis (2009) (53)
- Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity. (1988) (52)
- Allogeneic marrow transplantation for acute leukemia in relapse. (1982) (47)
- Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. (1991) (47)
- Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review. (2014) (47)
- PREDICTABILITY BEFORE TRANSPLANT OF HEPATIC COMPLICATIONS FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION (1989) (46)
- The ultrastructure of the human epidermis in chronic graft-versus-host disease. (1979) (43)
- The Pathology of bone marrow transplantation (1984) (41)
- Esophageal abnormalities in chronic graft-versus-host disease in humans. (1981) (39)
- Severe Hepatocellular Injury After Hematopoietic Cell Transplant: Incidence, Etiology, and Outcome (2009) (39)
- Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. (1982) (37)
- Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility (2015) (37)
- Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine. (1986) (37)
- Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. (1995) (36)
- Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation. (2000) (36)
- High-dose total-body irradiation and autologous marrow reconstitution in dogs: dose-rate-related acute toxicity and fractionation-dependent long-term survival. (1981) (36)
- Batten's disease: failure of allogeneic bone marrow transplantation to arrest disease progression in a canine model (1990) (34)
- DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors. (1994) (33)
- Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation. (1986) (33)
- Treatment of preleukemic syndromes with marrow transplantation. (1987) (30)
- Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP. (1992) (30)
- Iron overload, hematopoietic cell transplantation, and graft-versus-host disease (2009) (29)
- Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. (1988) (29)
- Marrow transplantation in hepatitis‐associated aplastic anemia (1984) (28)
- Fibrosing Cholestatic Hepatitis C After Hematopoietic Cell Transplantation: Report of 3 Fatal Cases (2015) (25)
- ENGRAFTMENT OF DLA‐NONIDENTICAL UNRELATED CANINE MARROW AFTER HIGH‐DOSE FRACTIONATED TOTAL BODY IRRADIATION (1982) (23)
- The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry. (1999) (23)
- Cutaneous macrophage infiltration in acute GvHD (2015) (23)
- Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation. (1987) (22)
- Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories. (1989) (21)
- Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model. (1999) (21)
- Cholestasis after hematopoietic cell transplantation. (1999) (21)
- Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation (2014) (20)
- Prevention of Fas-mediated hepatic failure by transferrin (2004) (20)
- Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates. Two distinct syndromes. (1982) (20)
- Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice. (2009) (19)
- Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States. (2011) (18)
- A Clinical Review: Cutaneous Manifestations of Acute and Chronic Graft‐versus‐Host Disease Following Bone Marrow Transplantation (1991) (18)
- Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation. (1998) (17)
- Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts. (1998) (17)
- Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors (1988) (15)
- Dimethyl myleran and autologous marrow grafting for the treatment of spontaneous canine lymphoma. (1977) (15)
- Pathology of Hematopoietic Cell Transplantation (2016) (15)
- Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I. (1991) (14)
- Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation. (2017) (12)
- Two cases of transfusion-associated graft-vs-host disease after open heart surgery. (1992) (11)
- Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy. (1987) (10)
- Monoclonal antibody therapy of spontaneous AKR T-cell leukemia. (1986) (10)
- Hepatic veno-occlusive disease following sirolimus-based immune suppression (2018) (10)
- Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2 (2008) (10)
- Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow. (1994) (7)
- Fatal hepatotoxicity associated with AMSA therapy. (1982) (7)
- Allogeneic bone marrow transplantation for canine ceroid lipofuscinosis. (1989) (7)
- Hepatic Complications of Hematopoietic Cell Transplantation (2007) (6)
- DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment. (1995) (6)
- Correction: Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype? (2008) (5)
- Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts. (1992) (4)
- Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization. (2002) (3)
- FAILURE OF ANTITHYMOCYTE SERUM POSTGRAFTING TO OVERCOME “RESISTANCE” TO DLANONIDENTICAL CANINE MARROW GRAFTS1 (1988) (3)
- Late onset of acute graft-versus-host disease. (1989) (3)
- Graft-versus-host disease. (1984) (2)
- Chronic Graft versus Host Disease: Interdisciplinary Management: Diagnosis and Staging (2009) (2)
- Is GVHD a model of PBC? Characterization of autoantibodies in GVHD (1998) (1)
- HISTOPATHOLOGIC DIAGNOSIS OF CHRONIC GRAFT VERSUS HOST DISEASE: NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: II. The 2014 Pathology Working Group Report (2015) (1)
- Pathology of Graft vs. Host Disease (2019) (1)
- The Pathological Spectrum of Hepatic GVHD (2019) (1)
- Induction ofHepatic Veno-occiusive Disease in Dogs (2007) (0)
- Capillaries, endothelial phenotype and inflammatory markers in the Skin of Systemic Sclerosis patients, does autologous stem cell transplant induce capillary regeneration? (2007) (0)
- TheSkinBiopsy intheDiagnosis ofAcuteGraft- Versus-Host Disease inMan (1977) (0)
- Chapter 23. Pathology of Hematopoietic Cell Transplantation (2007) (0)
- BONE MARROW TRANSPLANT (BMT) RECIPIENT POST‐TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT‐LPDs) DIFFER FROM THOSE IN SOLID ORGAN TRANSPLANT (SOT) RECIPIENTS.: ABSTRACT 35 (2000) (0)
- leukemia in long-term remission Hepatitis C virus infection and chronic liver disease in children with (2011) (0)
- [Alloimmunity and autoimmunity. I. Skin aspects]. (1989) (0)
- The function of a non-medical group as an adjunct in effecting a positive social and emotional adjustment during the treatment of scoliosis. (1977) (0)
- disease following prior therapy or antecedent hematologic disorders syndrome: similar outcomes in patients with de novo disease and syndrome or acute myeloid leukemia arising from myelodysplastic Hematopoietic cell transplantation in patients with myelodysplastic (2013) (0)
- ncillary Therapy and Supportive Care of Chronic raft-versus-Host Disease : National Institutes of ealth Consensus Development Project on Criteria or Clinical Trials in Chronic Graft-versus-Host isease : V . Ancillary Therapy and Supportive Care orking Group Report (2006) (0)
- Early Changes of Gut GVHD: Differential Diagnosis and Criteria for Crypt Cell Apoptosis (2019) (0)
- Hepatic Veno-occiusive Disease After Bone Marrow Transplantation (2007) (0)
- The Contributions of Pathology to the Diagnosis and Management of GVHD: Caveats and Lessons Learned (2019) (0)
- Surgical treatment of traumatic epilepsy (2021) (0)
- Osteopathic Graduate Medical Education: New Research Standards Needed (2014) (0)
- Persistent Gastrointestinal GVHD: The Application and Utility of Histologic Grading Schemes (2019) (0)
- Acute Hepatitic Onset of Liver GVHD Occurring 9 Months Post-transplant (2019) (0)
- Erythema multiforme-like skin eruptions localized to marrow aspiration sites after autologous marrow transplantation. (1985) (0)
- Some issues in the diagnosis of pituitary adenomas (1995) (0)
- The study of cerebrospinal fluid for the diagnosis of traumatic foci of crushing of the brain (1995) (0)
- Graft‐versus‐host‐induced cirrhosis: Possible mechanisms (1987) (0)
- Early GVHD with Follicular Rash (2019) (0)
- Pre-transplant Liver Disorders: Post-transplant Impact on Developing Venocclusive Disease/Sinusoidal Obstruction Syndrome and Other Hepatic Problems (2019) (0)
- Noninfectious Pulmonary Manifestation of GVHD: Bronchiolitis Obliterans Syndrome (2019) (0)
- Classic Papers and Current Comments Highlights of Leukemia Research (2002) (0)
- NOD/SCID mice Transplantation of allogeneic T cells alters iron homeostasis in (2011) (0)
- Alcoholization of the Hasser's node and sensory root from temporal access in trigeminal neuralgia (1986) (0)
- Lichenoid Inflammatory Phase of Chronic Skin GVHD (2019) (0)
- Pathobiology of Fatal Gastrointestinal GVHD (2019) (0)
- allogeneic hematopoietic cell transplantation: a study of 193 patients Hepatic injury after nonmyeloablative conditioning followed by (2013) (0)
- Cutaneous Microvasculature of Human Chronic GVHD Lacks the Vascular Rarefaction or the Abnormal Endothelial Cell Phenotype of Systemic Sclerosis (2009) (0)
- Rapidly Progressing Cholestatic Liver Failure After Allogeneic Stem Cell Transplant from Hepatitis C Virus-Positive Donor (FCHCV) (2019) (0)
- GVHD Manifesting as Sicca Syndrome (2019) (0)
- Lumbosacral vertebral compression syndrome (1980) (0)
- 88: Serial skin biopsies demonstrate reduced dermal fibrosis after autologous hemopoietic stem cell transplant (A-HSCT) for severe systemic sclerosis (SSS) (2007) (0)
- Transferrin (Tf) Mediated Protection of the Liver Against Fas-Induced Injury Requires Tf-Receptor Type 2 and Is Modulated by Baseline Plasma Iron Levels. (2006) (0)
- Manifestations of Chronic GVHD in Other Organ Systems (2019) (0)
- Hepatitis B virus infection and liver disease in patients undergoing bone marrow transplantation (BMT) (1989) (0)
- Biomarkers for Chronic Graft-versus-Host isease : National Institutes of Health Consensus evelopment Project on Criteria for Clinical Trials n Chronic Graft-versus-Host Disease : III . Biomarker orking Group Report (2006) (0)
- Chronic graft‐versus‐host disease and scleroderma pathology differ in endothelial cell phenotype (2008) (0)
- B ational Institutes of Health Consensus Development roject on Criteria for Clinical Trials in Chronic raft-versus-Host Disease : I . Diagnosis and Staging orking Group Report (2005) (0)
- Cutaneous Chronic GVHD: Sclerodermatous and Morpheic Variants (2019) (0)
- Mucosal Chronic GVHD Affecting the Oral Pharyngeal, Esophageal, and Anogenital Regions (2019) (0)
- Four-Year Follow-Up after High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc). (2006) (0)
- Immune Microenvironment in PTLDs: Comparison With Outcome and Other EBV+ Lymphoproliferative Disorders in Immunocompetenet and Immunodeficient Individuals (2012) (0)
- Multi-dimensional flow cytometric antigenic comparison of bone marrow from normal, AML and MDS patients (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Howard M. Shulman?
Howard M. Shulman is affiliated with the following schools:
